We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Severe/Extreme Hypertriglyceridemia and LDL Apheretic Treatment: Review of the Literature, Original Findings.
- Authors
Diakoumakou, Olga; Hatzigeorgiou, Georgios; Gontoras, Nikos; Boutsikou, Maria; Kolovou, Vana; Mavrogeni, Sophie; Giannakopoulou, Vassiliki; Kolovou, Genovefa D.
- Abstract
Hypertriglyceridemia (HTG) is a feature of numerous metabolic disorders including dyslipidemias, metabolic syndrome, and diabetes mellitus type 2 and can increase the risk of premature coronary artery disease. HTG may also be due to genetic factors (called primary HTG) and particularly the severe/extreme HTG (SEHTG), which is a usually rare genetic disorder. Even rarer are secondary cases of SEHTG caused by autoimmune disease. This review considers the causes of SEHTG, and their management including treatment with low density lipoprotein apheresis and analyzes the original findings.
- Subjects
HYPERTRIGLYCERIDEMIA; LOW density lipoproteins; METABOLIC disorders; CORONARY heart disease risk factors; DYSLIPIDEMIA; AUTOIMMUNE diseases; GENETIC disorders
- Publication
Cholesterol, 2014, p1
- ISSN
2090-1283
- Publication type
Article
- DOI
10.1155/2014/109263